Immunohistochemical Markers of Temporomandibular Disorders: A Review of the Literature
Abstract
:1. Introduction
2. Materials and Methods
2.1. Search Protocol
2.2. Data Analysis
3. Results
4. Discussion
4.1. Enzymes
4.2. Cytokines and Inflammatory Markers
4.3. Proteoglycans
4.4. Hormones
4.5. Miscellaneous
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Okeson, J.S. General Considerations in the Treatment of Temporomandibular Disorders. In Management of Temporomandibular Disorders and Occlusion, 6th ed.; Elsevier: Amsterdam, The Netherlands, 2008. [Google Scholar]
- Murphy, M.K.; MacBarb, R.F.; Wong, M.E.; Athanasiou, K.A. Temporomandibular Disorders: A Review of Etiology, Clinical Management, and Tissue Engineering Strategies. Int. J. Oral Maxillofac. Implant. 2013, 28, e393–e414. [Google Scholar] [CrossRef] [Green Version]
- Yadav, S.; Yang, Y.; Dutra, E.H.; Robinson, J.L.; Wadhwa, S. Temporomandibular Joint Disorders in Older Adults. J. Am. Geriatr. Soc. 2018, 66, 1213–1217. [Google Scholar] [CrossRef] [PubMed]
- Yoshida, H.; Fujita, S.; Iizuka, T.; Yoshida, T.; Sakakura, T. The specific expression of tenascin in the synovial membrane of the temporomandibular joint with internal derangement: An immunohistochemical study. Histochem. Cell Biol. 1997, 107, 479–484. [Google Scholar] [CrossRef] [PubMed]
- Mizoguchi, I.; Scott, P.G.; Dodd, C.M.; Rahemtulla, F.; Sasano, Y.; Kuwabara, M.; Satoh, S.; Saitoh, S.; Hatakeyama, Y.; Kagayama, M.; et al. An immunohistochemical study of the localization of biglycan, decorin and large chondroitin-sulphate proteoglycan in adult rat temporomandibular joint disc. Arch. Oral Biol. 1998, 43, 889–898. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, A.; Kumagai, S.; Kawashiri, S.; Takatsuka, S.; Nakagawa, K.; Yamamoto, E.; Matsumoto, N. Expression of matrix metalloproteinase-2 and -9 in synovial fluid of the temporomandibular joint accompanied by anterior disc displacement. J. Oral Pathol. Med. 2001, 30, 59–64. [Google Scholar] [CrossRef]
- Yoshida, H.; Fukumura, Y.; Fujita, S.; Nishida, M.; Iizuka, T. The distribution of cyclooxygenase-1 in human temporomandibular joint samples: An immunohistochemical study. J. Oral Rehabil. 2001, 28, 511–516. [Google Scholar] [CrossRef]
- Hu, L.; Liang, X.-H.; Zhu, G.-Q.; Hu, J.; Shi, Z.-D. Expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in synovial fluid of patients with temporomandibular disorders. Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chin. J. Stomatol. 2008, 43, 160–163. Available online: https://www.ncbi.nlm.nih.gov/pubmed/18788551 (accessed on 25 October 2022).
- Matsumoto, T.; Tojyo, I.; Kiga, N.; Hiraishi, Y.; Fujita, S. Expression of adamts-5 in deformed human temporomandibular joint discs. Histol. Histopathol. 2008, 23, 1485–1493. [Google Scholar] [CrossRef]
- Almeida, L.E.; Caporal, K.; Ambros, V.; Azevedo, M.; Noronha, L.; Leonardi, R.; Trevilatto, P.C. Immunohistochemical expression of matrix metalloprotease-2 and matrix metalloprotease-9 in the disks of patients with temporomandibular joint dysfunction. J. Oral Pathol. Med. 2014, 44, 75–79. [Google Scholar] [CrossRef] [Green Version]
- Loreto, C.; Leonardi, R.; Musumeci, G.; Pannone, G.; Castorina, S. An ex vivo study on immunohistochemical localization of MMP-7 and MMP-9 in temporomandibular joint discs with internal derangement. Eur. J. Histochem. 2013, 57, e12. [Google Scholar] [CrossRef] [Green Version]
- Kapila, S.; Wang, W.; Uston, K. Matrix Metalloproteinase Induction by Relaxin Causes Cartilage Matrix Degradation in Target Synovial Joints. Ann. N. Y. Acad. Sci. 2009, 1160, 322–328. [Google Scholar] [CrossRef]
- Marchetti, C.; Cornaglia, I.; Casasco, A.; Bernasconi, G.; Baciliero, U.; Stetler-Stevenson, W. Immunolocalization of gelatinase-A (matrix metalloproteinase-2) in damaged human temporomandibular joint discs. Arch. Oral Biol. 1999, 44, 297–304. [Google Scholar] [CrossRef] [PubMed]
- Quinn, J.H.; Kent, J.N.; Moise, A.; Lukiw, W.J. Cyclooxygenase-2 in synovial tissue and fluid of dysfunctional temporomandibular joints with internal derangement. J. Oral Maxillofac. Surg. 2000, 58, 1229–1232. [Google Scholar] [CrossRef] [PubMed]
- Puzas, J.E.; Landeau, J.M.; Tallents, R.; Albright, J.; Schwarz, E.M.; Landesberg, R. Degradative pathways in tissues of the temporomandibular joint. Use of in vitro and in vivo models to characterize matrix metalloproteinase and cytokine activity. Cells Tissues Organs 2001, 169, 248–256. [Google Scholar] [CrossRef] [PubMed]
- Yoshida, H.; Fukumura, Y.; Fujita, S.; Nishida, M.; Iizuka, T. The expression of cyclooxygenase-2 in human temporomandibular joint samples: An immunohistochemical study. J. Oral Rehabil. 2002, 29, 1146–1152. [Google Scholar] [CrossRef] [PubMed]
- Yoshida, K.; Takatsuka, S.; Hatada, E.; Nakamura, H.; Tanaka, A.; Ueki, K.; Nakagawa, K.; Okada, Y.; Yamamoto, E.; Fukuda, R. Expression of matrix metalloproteinases and aggrecanase in the synovial fluids of patients with symptomatic temporomandibular disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2006, 102, 22–27. [Google Scholar] [CrossRef]
- Yoshida, K.; Takatsuka, S.; Tanaka, A.; Hatada, E.; Nakamura, H.; Nakagawa, K.; Okada, Y. Aggrecanase analysis of synovial fluid of temporomandibular joint disorders. Oral Dis. 2005, 11, 299–302. [Google Scholar] [CrossRef] [Green Version]
- Leonardi, R.; Migliore, M.R.; Almeida, L.E.; Trevilatto, P.C.; Loreto, C. Limited fatty infiltration due to apoptosis in human degenerated temporomandibular joint disks: An immunohistochemical study. J. Craniofac. Surg. 2010, 21, 1508–1511. [Google Scholar] [CrossRef]
- Loreto, C.; Almeida, L.E.; Trevilatto, P.; Leonardi, R. Apoptosis in displaced temporomandibular joint disc with and without reduction: An immunohistochemical study. J. Oral Pathol. Med. 2011, 40, 103–110. [Google Scholar] [CrossRef] [Green Version]
- Nascimento, G.C.; Rizzi, E.; Gerlach, R.F.; Leite-Panissi, C.R.A. Expression of mmp-2 and mmp-9 in the rat trigeminal gangli-on during the development of temporomandibular joint inflammation. Braz. J. Med. Biol. Res. 2013, 46, 956–967. [Google Scholar] [CrossRef] [Green Version]
- Perotto, J.H.; Camejo, F.D.A.; Doetzer, A.D.; Almeida, L.E.; Azevedo, M.; Olandoski, M.; Noronha, L.; Trevilatto, P.C. Expression of MMP-13 in human temporomandibular joint disc derangement and osteoarthritis. Cranio® 2017, 36, 161–166. [Google Scholar] [CrossRef] [PubMed]
- Kim, Y.-K.; Kim, S.-G.; Kim, B.-S.; Lee, J.-Y.; Yun, P.-Y.; Bae, J.-H.; Oh, J.-S.; Ahn, J.-M.; Kim, J.-S.; Lee, S.-Y. Analysis of the cytokine profiles of the synovial fluid in a normal temporomandibular joint: Preliminary study. J. Cranio-Maxillofac. Surg. 2012, 40, e337–e341. [Google Scholar] [CrossRef] [PubMed]
- Fu, K.-Y.; Ma, X.; Zhang, Z.; Pang, X.; Chen, W. Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J. Orofac. Pain 1995, 9, 131–137. Available online: https://www.ncbi.nlm.nih.gov/pubmed/7488982 (accessed on 25 October 2022). [PubMed]
- Ogura, N.; Tobe, M.; Sakamaki, H.; Kujiraoka, H.; Akiba, M.; Abiko, Y.; Nagura, H. Interleukin-1β induces interleukin-6 mRNA expression and protein production in synovial cells from human temporomandibular joint. J. Oral Pathol. Med. 2002, 31, 353–360. [Google Scholar] [CrossRef]
- Sato, J.; Segami, N.; Nishimura, M.; Demura, N.; Yoshimura, H.; Yoshitake, Y.; Nishikawa, K. Expression of interleukin 6 in synovial tissues in patients with internal derangement of the temporomandibular joint. Br. J. Oral Maxillofac. Surg. 2003, 41, 95–101. [Google Scholar] [CrossRef]
- Camejo, F.D.A.; Azevedo, M.; Ambros, V.; Caporal, K.S.T.; Doetzer, A.D.; Almeida, L.E.; Olandoski, M.; Noronha, L.; Trevilatto, P.C. Interleukin-6 expression in disc derangement of human temporomandibular joint and association with osteoarthrosis. J. Cranio-Maxillofac. Surg. 2017, 45, 768–774. [Google Scholar] [CrossRef] [Green Version]
- Yoshida, H.; Fujita, S.; Nishida, M.; Iizuka, T. The expression of substance P in human temporomandibular joint samples: An immunohistochemical study. J. Oral Rehabil. 1999, 26, 338–344. [Google Scholar] [CrossRef]
- Suzuki, T.; Bessho, K.; Segami, N.; Nojima, T.; Iizuka, T. Bone morphogenetic protein-2 in temporomandibular joints with internal derangement. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 1999, 88, 670–673. [Google Scholar] [CrossRef]
- Yoshida, H.; Yoshida, T.; Iizuka, T.; Sakakura, T.; Fujita, S. The expression of transforming growth factor beta (TGF-beta) in the synovial membrane of human temporomandibular joint with internal derangement: A comparison with tenascin expression. J. Oral Rehabil. 1999, 26, 814–820. [Google Scholar] [CrossRef]
- Leonardi, R.; Villari, L.; Piacentini, C.; Bernasconi, G.; Baciliero, U.; Travali, S. Cd44 standard form (cd44h) expression and distribution in dysfunctional human temporomandibular joint discs. Int. J. Oral Maxillofac. Surg. 2000, 29, 296–300. Available online: https://www.ncbi.nlm.nih.gov/pubmed/11030403 (accessed on 25 October 2022). [CrossRef]
- Suzuki, T.; Segami, N.; Nishimura, M.; Nojima, T. Co-expression of interleukin-1beta and tumor necrosis factor alpha in synovial tissues and synovial fluids of temporomandibular joint with internal derangement: Comparision with histological grading of synovial inflammation. J. Oral Pathol. Med. 2002, 31, 549–557. [Google Scholar] [CrossRef]
- Tobe, M.; Ogura, N.; Abiko, Y.; Nagura, H. Interleukin-1β stimulates interleukin-8 production and gene expression in synovial cells from human temporomandibular joint. J. Oral Maxillofac. Surg. 2002, 60, 741–747. [Google Scholar] [CrossRef]
- Leonardi, R.; Muzio, L.L.; Bernasconi, G.; Caltabiano, C.; Piacentini, C. Expression of vascular endothelial growth factor in human dysfunctional temporomandibular joint discs. Arch. Oral Biol. 2003, 48, 185–192. [Google Scholar] [CrossRef] [PubMed]
- Suzuki, T.; Segami, N.; Nishimura, M.; Sato, J.; Nojima, T. Bradykinin expression in synovial tissues and synovial fluids obtained from patients with internal derangement of the temporomandibular joint. Cranio® 2003, 21, 265–270. [Google Scholar] [CrossRef] [PubMed]
- Sato, J.; Segami, N.; Nishimura, M.; Kaneyama, K.; Demura, N.; Yoshimura, H. Relation between the expression of vascular endothelial growth factor in synovial tissues and the extent of joint effusion seen on magnetic resonance imaging in patients with internal derangement of the temporomandibular joint. Br. J. Oral Maxillofac. Surg. 2003, 41, 88–94. [Google Scholar] [CrossRef] [PubMed]
- Tanimoto, K.; Suzuki, A.; Ohno, S.; Honda, K.; Tanaka, N.; Doi, T.; Yoneno, K.; Ohno-Nakahara, M.; Nakatani, Y.; Ueki, M.; et al. Effects of TGF-β on Hyaluronan Anabolism in Fibroblasts Derived from the Synovial Membrane of the Rabbit Temporomandibular Joint. J. Dent. Res. 2004, 83, 40–44. [Google Scholar] [CrossRef]
- Kaneyama, K.; Segami, N.; Sun, W.; Sato, J.; Fujimura, K. Analysis of tumor necrosis factor-α, interleukin-6, interleukin-1β, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2004, 99, 276–284. [Google Scholar] [CrossRef]
- Yamaguchi, A.; Tojyo, I.; Yoshida, H.; Fujita, S. Role of hypoxia and interleukin-1β in gene expressions of matrix metalloproteinases in temporomandibular joint disc cells. Arch. Oral Biol. 2005, 50, 81–87. [Google Scholar] [CrossRef]
- Ogura, N.; Tobe, M.; Sakamaki, H.; Nagura, H.; Abiko, Y.; Kondoh, T. Tumor necrosis factor-alpha increases chemokine gene expression and production in synovial fibroblasts from human temporomandibular joint. J. Oral Pathol. Med. 2005, 34, 357–363. [Google Scholar] [CrossRef]
- Sato, J.; Segami, N.; Nishimura, M.; Yoshitake, Y.; Kaneyama, K.; Kitagawa, Y. Expression of interleukin 8 in synovial tissues in patients with internal derangement of the temporomandibular joint and its relationship with clinical variables. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2007, 103, 467–474. [Google Scholar] [CrossRef]
- Matsumoto, K.; Honda, K.; Ohshima, M.; Yamaguchi, Y.; Nakajima, I.; Micke, P.; Otsuka, K. Cytokine profile in synovial fluid from patients with internal derangement of the temporomandibular joint: A preliminary study. Dentomaxillofacial Radiol. 2006, 35, 432–441. [Google Scholar] [CrossRef]
- Deschner, J.; Rath-Deschner, B.; Reimann, S.; Bourauel, C.; Götz, W.; Jepsen, S.; Jäger, A. Regulatory effects of biophysical strain on rat TMJ discs. Ann. Anat.-Anat. Anz. 2007, 189, 326–328. [Google Scholar] [CrossRef] [PubMed]
- Ke, J.; Long, X.; Liu, Y.; Zhang, Y.; Li, J.; Fang, W.; Meng, Q. Role of NF-κB in TNF-α-induced COX-2 Expression in Synovial Fibroblasts from Human TMJ. J. Dent. Res. 2007, 86, 363–367. [Google Scholar] [CrossRef] [PubMed]
- Tojyo, I.; Yamaguchi, A.; Nitta, T.; Yoshida, H.; Fujita, S.; Yoshida, T. Effect of hypoxia and interleukin-1? on expression of tenascin-C in temporomandibular joint. Oral Dis. 2007, 14, 45–50. [Google Scholar] [CrossRef] [PubMed]
- Leonardi, R.; Almeida, L.E.; Rusu, M.; Sicurezza, E.; Palazzo, G.; Loreto, C. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression Correlates to Temporomandibular Joint Disk Degeneration. J. Craniofac. Surg. 2011, 22, 504–508. [Google Scholar] [CrossRef]
- Camejo, F.D.A.; Almeida, L.E.; Doetzer, A.D.; Caporal, K.S.T.; Ambros, V.; Azevedo, M.; Alanis, L.R.A.; Olandoski, M.; Noronha, L.; Trevilatto, P.C. FasL expression in articular discs of human temporomandibular joint and association with osteoarthrosis. J. Oral Pathol. Med. 2013, 43, 69–75. [Google Scholar] [CrossRef] [Green Version]
- Sicurezza, E.; Loreto, C.; Musumeci, G.; Almeida, L.E.; Rusu, M.; Grasso, C.; Leonardi, R. Expression of β-defensin 4 on temporomandibular joint discs with anterior displacement without reduction. J. Cranio-Maxillofac. Surg. 2013, 41, 821–825. [Google Scholar] [CrossRef]
- Ohta, K.; Naruse, T.; Kato, H.; Ishida, Y.; Nakagawa, T.; Ono, S.; Shigeishi, H.; Takechi, M. Differential regulation by IFN-γ on TNF-α-induced chemokine expression in synovial fibroblasts from temporomandibular joint. Mol. Med. Rep. 2017, 16, 6850–6857. [Google Scholar] [CrossRef] [Green Version]
- Kaya, G.; Yavuz, G.Y.; Kızıltunç, A. Expression of chemerin in the synovial fluid of patients with temporomandibular joint disorders. J. Oral Rehabil. 2018, 45, 289–294. [Google Scholar] [CrossRef]
- Sorenson, A.; Hresko, K.; Butcher, S.; Pierce, S.; Tramontina, V.; Leonardi, R.; Loreto, C.; Bosio, J.; Almeida, L.E. Expression of Interleukin-1 and temporomandibular disorder: Contemporary review of the literature. Cranio® 2017, 36, 268–272. [Google Scholar] [CrossRef] [Green Version]
- Luo, P.; Feng, C.; Jiang, C.; Ren, X.; Gou, L.; Ji, P.; Xu, J. IL-37b alleviates inflammation in the temporomandibular joint cartilage via IL-1R8 pathway. Cell Prolif. 2019, 52, e12692. [Google Scholar] [CrossRef] [PubMed]
- Kobayashi, K.; Jokaji, R.; Miyazawa-Hira, M.; Takatsuka, S.; Tanaka, A.; Ooi, K.; Nakamura, H.; Kawashiri, S. Elastin-derived peptides are involved in the processes of human temporomandibular disorder by inducing inflammatory responses in synovial cells. Mol. Med. Rep. 2017, 16, 3147–3154. [Google Scholar] [CrossRef] [Green Version]
- Yoshida, H.; Fukumura, Y.; Nishida, M.; Fujita, S.; Iizuka, T. The immunohistochemical distribution of vimentin in human temporomandibular joint samples. J. Oral Rehabil. 2004, 31, 47–51. [Google Scholar] [CrossRef] [PubMed]
- Toriya, N.; Takuma, T.; Arakawa, T.; Abiko, Y.; Sasano, Y.; Takahashi, I.; Sakakura, Y.; Rahemtulla, F.; Mizoguchi, I. Expression and localization of versican during postnatal development of rat temporomandibular joint disc. Histochem. Cell Biol. 2005, 125, 205–214. [Google Scholar] [CrossRef]
- Yoshida, H.; Yoshida, T.; Iizuka, T.; Sakakura, T.; Fujita, S. An immunohistochemical and in situ hybridization study of the expression of tenascin in synovial membranes from human temporomandibular joints with internal derangement. Arch. Oral Biol. 1996, 41, 1081–1085. [Google Scholar] [CrossRef] [PubMed]
- Kuwabara, M.; Takuma, T.; Scott, P.G.; Dodd, C.M.; Mizoguchi, I. Biochemical and immunohistochemical studies of the protein expression and localization of decorin and biglycan in the temporomandibular joint disc of growing rats. Arch. Oral Biol. 2002, 47, 473–480. [Google Scholar] [CrossRef]
- Leonardi, R.; Villari, L.; Piacentini, C.; Bernasconi, G.; Travali, S.; Caltabiano, C. Immunolocalization of vimentin and alpha-smooth muscle actin in dysfunctional human temporomandibular joint disc samples. J. Oral Rehabil. 2002, 29, 282–286. [Google Scholar] [CrossRef]
- Yoshida, H.; Fujita, S.; Nishida, M.; Iizuka, T.; Yoshida, T.; Sakakura, T. The expression of tenascin mRNA in human temporomandibular joint specimens. J. Oral Rehabil. 2002, 29, 765–769. [Google Scholar] [CrossRef]
- Kondoh, T.; Hamada, Y.; Iino, M.; Takahashi, T.; Kikuchi, T.; Fujikawa, K.; Seto, K. Regional differences of type II collagen synthesis in the human temporomandibular joint disc: Immunolocalization study of carboxy-terminal type II procollagen peptide (chondrocalcin). Arch. Oral Biol. 2003, 48, 621–625. [Google Scholar] [CrossRef]
- Leonardi, R.; Michelotti, A.; Farella, M.; Caltabiano, R.; Lanzafame, S. Fibronectin Upregulation in Human Temporomandibular Joint Disks with Internal Derangement. J. Craniofac. Surg. 2004, 15, 678–683. [Google Scholar] [CrossRef] [Green Version]
- Paegle, D.; Holmlund, A.; Hjerpe, A. Expression of proteoglycan mRNA in patients with painful clicking and chronic closed lock of the temporomandibular joint. Int. J. Oral Maxillofac. Surg. 2005, 34, 656–658. [Google Scholar] [CrossRef] [PubMed]
- De Moraes, L.O.; Lodi, F.R.; Gomes, T.S.; Marques, S.R.; Fernandes, J.A., Jr.; Oshima, C.T.; Alonso, L.G. Immunohisto-chemical expression of collagen type iv antibody in the articular disc of the temporomandibular joint of human fetuses. Ital. J. Anat. Embryol. 2008, 113, 91–95. Available online: https://www.ncbi.nlm.nih.gov/pubmed/18702236 (accessed on 25 October 2022).
- Li, J.; Long, X.; Ke, J.; Meng, Q.-G.; Lee, C.C.W.; Doocey, J.M.; Zhu, F. Regulation of HAS expression in human synovial lining cells of TMJ by IL-1β. Arch. Oral Biol. 2008, 53, 60–65. [Google Scholar] [CrossRef] [PubMed]
- Natiella, J.R.; Burch, L.; Fries, K.M.; Upton, L.G.; Edsberg, L.E. Analysis of the Collagen I and Fibronectin of Temporomandibular Joint Synovial Fluid and Discs. J. Oral Maxillofac. Surg. 2009, 67, 105–113. [Google Scholar] [CrossRef]
- Matsumoto, T.; Inayama, M.; Tojyo, I.; Kiga, N.; Fujita, S. Expression of hyaluronan synthase 3 in deformed human temporomandibular joint discs: In vivo and in vitro studies. Eur. J. Histochem. 2010, 54, e50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kiga, N.; Tojyo, I.; Matsumoto, T.; Hiraishi, Y.; Shinohara, Y.; Fujita, S. Expression of lumican related to CD34 and VEGF in the articular disc of the human temporomandibular joint. Eur. J. Histochem. 2010, 54, e34. [Google Scholar] [CrossRef] [PubMed]
- Fang, W.; Friis, T.E.; Long, X.; Xiao, Y. Expression of chondromodulin-1 in the temporomandibular joint condylar cartilage and disc. J. Oral Pathol. Med. 2009, 39, 356–360. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kiga, N.; Tojyo, I.; Matsumoto, T.; Hiraishi, Y.; Shinohara, Y.; Makino, S.; Fujita, S. Expression of lumican and fibromodulin following interleukin-1 beta stimulation of disc cells of the human temporomandibular joint. Eur. J. Histochem. 2011, 55, e11. [Google Scholar] [CrossRef]
- Leonardi, R.; Almeida, L.E.; Loreto, C. Lubricin immunohistochemical expression in human temporomandibular joint disc with internal derangement. J. Oral Pathol. Med. 2011, 40, 587–592. [Google Scholar] [CrossRef]
- Leonardi, R.; Rusu, M.; Loreto, F.; Loreto, C.; Musumeci, G. Immunolocalization and expression of lubricin in the bilaminar zone of the human temporomandibular joint disc. Acta Histochem. 2012, 114, 1–5. [Google Scholar] [CrossRef]
- Hill, A.; Duran, J.; Purcell, P. Lubricin Protects the Temporomandibular Joint Surfaces from Degeneration. PLoS ONE 2014, 9, e106497. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shinohara, Y.; Okamoto, K.; Goh, Y.; Kiga, N.; Tojyo, I.; Fujita, S. Inhibition of fibrous adhesion formation in the temporomandibular joint of tenascin-C knockout mice. Eur. J. Histochem. 2014, 58, 2337. [Google Scholar] [CrossRef] [PubMed]
- Leonardi, R.; Perrotta, R.; Almeida, L.; Loreto, C.; Musumeci, G. Lubricin in synovial fluid of mild and severe temporomandibular joint internal derangements. Med. Oral Patol. Oral Y Cirugía Bucal. 2016, 21, e793–e799. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Puri, J.; Hutchins, B.; Bellinger, L.L.; Kramer, P.R. Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint. Reprod. Biol. Endocrinol. 2009, 7, 155. Available online: https://www.ncbi.nlm.nih.gov/pubmed/20043825 (accessed on 25 October 2022). [CrossRef] [Green Version]
- Naqvi, T.; Duong, T.T.; Hashem, G.; Shiga, M.; Zhang, Q.; Kapila, S. Relaxin’s induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants. Thromb. Haemost. 2005, 7, 1–11. [Google Scholar] [CrossRef] [Green Version]
- Hashem, G.; Zhang, Q.; Hayami, T.; Chen, J.; Wang, W.; Kapila, S. Relaxin and β-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: Progesterone prevents matrix loss. Thromb. Haemost. 2006, 8, R98. [Google Scholar] [CrossRef] [Green Version]
- Wang, W.; Hayami, T.; Kapila, S. Female hormone receptors are differentially expressed in mouse fibrocartilages. Osteoarthr. Cartil. 2009, 17, 646–654. [Google Scholar] [CrossRef] [Green Version]
- McDaniel, J.S.; Babu, R.A.S.; Navarro, M.M.; LeBaron, R.G. Transcriptional regulation of proteoglycan 4 by 17β-estradiol in immortalized baboon temporomandibular joint disc cells. Eur. J. Oral Sci. 2014, 122, 100–108. [Google Scholar] [CrossRef] [Green Version]
- Park, Y.; Chen, S.; Ahmad, N.; Hayami, T.; Kapila, S. Estrogen Selectively Enhances TMJ Disc but Not Knee Meniscus Matrix Loss. J. Dent. Res. 2019, 98, 1532–1538. [Google Scholar] [CrossRef]
- Jiang, S.-J.; Li, W.; Li, Y.-J.; Fang, W.; Long, X. Dickkopf-related protein 1 induces angiogenesis by upregulating vascular endothelial growth factor in the synovial fibroblasts of patients with temporomandibular joint disorders. Mol. Med. Rep. 2015, 12, 4959–4966. [Google Scholar] [CrossRef] [Green Version]
- Huang, Q.; Singh, B.; Sharawy, M. Immunohistochemical analysis of Bcl-2 and Bax oncoproteins in rabbit craniomandibular joint. Arch. Oral Biol. 2003, 49, 143–148. [Google Scholar] [CrossRef] [PubMed]
- Fujimura, K.; Segami, N.; Yoshitake, Y.; Tsuruoka, N.; Kaneyama, K.; Sato, J.; Kobayashi, S. Electrophoretic separation of the synovial fluid proteins in patients with temporomandibular joint disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2005, 101, 463–468. [Google Scholar] [CrossRef] [PubMed]
- Loreto, C.; Castro, E.L.; Musumeci, G.; Loreto, F.; Rapisarda, G.; Rezzani, R.; Castorina, S.; Leonardi, R.; Rusu, M.C. Aquaporin 1 expression in human temporomandibular disc. Acta Histochem. 2012, 114, 744–748. [Google Scholar] [CrossRef]
- Loreto, C.; Galanti, C.; Almeida, L.E.; Leonardi, R.; Pannone, G.; Musumeci, G.; Carnazza, M.L.; Caltabiano, R. Expression and localization of aquaporin-1 in temporomandibular joint disc with internal derangement. J. Oral Pathol. Med. 2012, 41, 642–647. [Google Scholar] [CrossRef] [PubMed]
- Leonardi, R.; Caltabiano, M.; Cascone, P.; Loreto, C. Expression of Heat Shock Protein 27 (HSP27) in Human Temporomandibular Joint Discs of Patients with Internal Derangement. J. Craniofac. Surg. 2002, 13, 713–717. [Google Scholar] [CrossRef] [PubMed]
- Castorina, S.; Lombardo, C.; Castrogiovanni, P.; Musumeci, G.; Barbato, E.; Almeida, L.E.; Leonardi, R. P53 and vegf expres-sion in human temporomandibular joint discs with internal derangement correlate with degeneration. J. Biol. Regul. Homeost. Agents 2019, 33, 1657–1662. [Google Scholar] [CrossRef] [PubMed]
Authors | IHC Marker | Study Design and Tissue Expression | Results | Conclusions |
---|---|---|---|---|
Kapila et al. (1995) [12] | MMP | Rabbit discs | MMPs, namely proMMP-9, proMMP-2, proMMP-1, and proMMP-3 were detected in TMJ articular discs. | Proteinases characterized in rabbit TMJ discs |
Marchetti et al. (1999) [13] | MMP-2 | Human discs | Positive immunoreaction pattern for MMP-2. Fibroblast-, chondroblast- and osteoblast-like cells displayed a positive cytoplasmic reaction. Structural modifications of the articular disc could be specific responses to changes in the function of the TMJ. | MMP-2 produced disc alteration |
Quinn et al. (2000) [14] | Cyclooxygenase-2 | Human synovial fluid | COX-2 is present in the TMJ synovial tissue and fluid from patients with internal derangement. Therefore, COX-2 antagonists may be indicated in the treatment of TMJ arthralgia. | COX-2 expression in internal derangements |
Tanaka et al. (2001) [6] | MMPs | Human synovial fluid | Quantitative analysis showed that the degree of MMP-2 and MMP-9 expression was higher in human patients with ADDwoR than in human patients with ADDwR. | MMP-2 and MMP-9 associated with TMD |
Yoshida et al. (2001) [7] | Cyclooxygenase-1,2 | Human synovial membranes | COX-1 may be an important mechanism for maintaining normal homeostasis at the endothelial cells and fibroblasts with internal derangement of TMJ. | Cyclooxygenase-1 associated with TMJ homeostasis |
Puzas et al. (2001) [15] | MMPs and Cytokines | Mice discs | The presence of a MMP-9 (92-kD gelatinase) in TMJ disc and articular cells likely function in the degradative process. Additionally, this enzyme is under the control of pro-inflammatory cytokines whereby TGFbeta and IL-1 stimulate and PGE(2) inhibits its activity. | MMP-9 associated with degenerative processes |
Yoshida et al. (2002) [16] | Cyclooxygenase-2 | Human disk and synovial membranes | There were obvious distinction of COX-2 immunoreactivity between the control specimens and internal derangement cases, in the region of posterior and/or anterior loose connective tissues. intensive COX-2 expression was detected in the synovial membrane of internal derangement cases. | COX-2 expression and TMD |
Yoshida et al. (2006) [17] | MMP and aggrecanase | Human synovial fluid | MMP-2, -9, and aggrecanase expression in the ID group were significantly higher than those in the normal group. Those with anterior disc displacement without reduction and severe OA showed significantly high expression of MMP-9 compared with other disease subgroups. | MMP-2, 9 and aggrecanase in TMD. |
Yoshida et al. (2005) [18] | Aggrecanase | Human synovial fluid | Aggrecanase expression in TMJD group were significantly higher than that in the normal control group. | Aggrecanase associated with TMD |
Hu et al. (2008) [8] | Urokinase-Type Plasminogen Activator and Urokinase-Type Plasminogen Activator Receptor | Human synovial fluid | uPA and uPAR in the synovial fluid may play a role in the pathogenesis of TMD, and the level of uPA and uPAR in synovial fluid of TMD could be used as a biochemical markers to reflect pathological degree of TMD. | uPA and uPAR associated with TMD |
Matsumoto et al. (2008) [9] | Disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS-5) | Human discs | ADAMTS-5 is related to deformation and destruction of human TMJ discs affected by internal derangement. | ADAMTS-5 associated with TMD |
Leonardi et al. (2010) [19] | Caspase 3 | Human discs | Fatty degeneration is limited by apoptosis, with adipocytes being immunolabeled by caspase 3 antibody. | |
Loreto et al. (2011) [20] | Caspase 3 | Human discs | A greater proportion of caspase 3-positive cells were found in ADDwR and ADDwoR than in control discs. | Caspase 3 associated with TMD |
Loreto et al. (2013) [11] | MMP-7 and MMP-9 | Human discs | MMP upregulation in discs from patients contributes to disc damage. | MMP associated with TMD |
Nascimento et al. (2013) [21] | MMP-2 and MMP-9 | Rat trigeminal ganglion | MMP expression in the trigeminal ganglion was shown to vary during the phases of the inflammatory process. MMP-9 regulated the early phase and MMP-2 participated in the late phase of this process. Furthermore, increases in plasma extravasation in periarticular tissue and myeloperoxidase activity in the joint tissue, which occurred throughout the inflammation process, were diminished by treatment with DOX, a nonspecific MMP inhibitor. | MMP-2 and MMP-9 associated with process of TMJ inflammation |
Almeida et al. (2015) [10] | MMP-2 and MMP-9 | Human discs | MMP-2 expression was elevated in the disks of patients with displacement and without reduction. MMP-9 expression was not statistically elevated in the disks of patients with displacement and without reduction. | Elevation of MMP-2 in TMD. |
Perroto et al. (2018) [22] | MMP-13 | Human discs | MMP-13 is not significantly involved in collagen degradation. | Inflammatory cascade? |
Authors | IHC Marker | Study Design and Tissue Expression | Results | Conclusions |
---|---|---|---|---|
Fu et al. (1995) [24] | IL-6 | Human synovial fluid | Interleukin-6 level was greater than 100 U/mL in 13 of 18 patients with degenerative joint disease and in 5 of 12 patients with disc displacement. However, the interleukin-6 level was less than 100 U/mL (range, 20 to 75 U/mL) in all patients with masticatory muscle disorder. | IL-6 associated with acute TMD |
Fujita et al. (1999) [28] | P substance | Human disc and synovial fluid | Expression of substance P seems to be closely related to histopathological changes of the human TMJ with internal derangement. | Substance P associated with internal derangement |
Suzuki et al. (1999) [29] | BMP-2 | Human discs | BMP-2 was predominantly localized in chondrocytes around the damaged areas of the articular disks. BMP-2 expression was also found in synovial cells and endothelial cells of blood vessels. | BMP-2 associated with TMD |
Yoshida et al. (1999) [30] | CD34 antigen | Human disc and synovial membrane | CD34 is suggested to be correlated with the process of angiogenesis induced by internal derangement of the TMJ. | Vascular endothelium and angiogenesis |
Yoshida et al. (1999) [30] | TGF-beta and Tenascin | Human synovial membranes | TGF-beta and tenascin were distributed in the affected synovial membrane of TMJ with internal derangement. These findings suggested that TGF-beta and tenascin might have a close relationship with synovitis, followed by tissue repair. | TGF-beta and tenascin in TMD |
Leonardi et al. (2000) [31] | CD44 Standard Form | Human discs | The up-regulation of CD44H observed in some dysfunctional TMJ discs seems to indicate a prevention of apoptosis in fibroblast-like cells and an important role in phenotypical change of fibrochondrocytes into chondroblastlike cells, enabling the aggregation of chondroid tissue pericellular matrix components. | Prevention of apoptosis in TMJ discs |
Ogura et al. (2002) [25] | IL-1 Beta and IL-6 | Human synovial cells | IL-1 beta increased IL-6 production in synovial cells. Enhanced production of IL-6, which is associated with bone resorption and inflammatory response, seems to be related to the progression of TMD. | IL-6 associated with TMD |
Suzuki et al. (2002) [32] | IL-1 Beta and TNF-alpha | Human synovial fluids | IL-1beta and TNF-alpha may be involved with TMJ internal derangement and coordinately play a role in pathogenesis of TMJ internal derangement. | |
Tobe et al. (2002) [33] | IL-1 Beta and IL-8 | Human synovial cells | IL-1beta stimulated IL-8 production through an increase in IL-8 gene expression in HTS cells, which may be associated with the increase in infiltrating inflammatory cells seen in the synovial membrane of TMJ disorders. | IL-8 associated with TMD |
Leonardi et al. (2003) [34] | VEGF | Human Disks | In disc specimens from internal derangement of the TMJ with significant tissue degeneration/regeneration, VEGF was consistently expressed. | VEGF expression in human disc with TMD |
Sato et al. (2003) [26] | IL-6 | Human synovial tissue | In synovial tissues from 21 of the 46 joints with internal derangement, interleukin 6 (IL-6) was expressed in the synovial lining cells and in the mononuclear cells infiltrating the periphery of the blood vessels. | IL-6 associated with TMD |
Suzuki et al. (2003) [35] | Bradykinin | Human synovial tissues and fluids | Bradykinin was also detected in 19 patients’ TMJ synovial fluids and the average of bradykinin concentration in the synovial fluids of patients was higher than that of the healthy controls. Although a statistically significant correlation was not observed, these findings support the hypothesis that bradykinin may also be involved in the pathogenesis of TMJ pain and synovitis. | Bradykinin associated with pathogenesis of TMD pain and synovitis. |
Sato et al. (2003) [36] | VEGF | Human synovial tissues | VEGF may have an important role in the genesis of joint effusion. | VEGF and joint effusion |
Tanimoto et al. (2004) [37] | TGF-beta | Rabbit synovial membranes | TGF-beta 1 enhances the expression of HAS2 mRNA in the TMJ synovial membrane fibroblasts and may contribute to the production of high-molecular-weight HA in the joint fluid. | TGF-beta associated with high molecular weight hyaluronan and more viscous fluid |
Kaneyama et al. (2005) [38] | Tumor Necrosis Factor-Alpha, interleukin-6, interleukin-1beta, Soluble Tumor Necrosis Factor Receptors I and II, interleukin-6 Soluble Receptor, interleukin-1 Soluble Receptor Type II, interleukin-1 Receptor Antagonist | Human synovial fluid | The concentrations of TNF-alpha, IL-6, IL-1beta, sTNFR-I, and sTNFR-II were significantly higher in the synovial fluid of patients than in controls (p < 0.05). TNF-alpha level was positively correlated with those of IL-6, sTNFR-I, and sTNFR-II. In particular, there was a highly significant positive correlation between sTNFR-I and sTNFR-II. | All associated with TMD |
Yamaguchi et al. (2005) [39] | Hypoxia and interleukin-1beta and MMPs | Rabbit discs | The results showed that the combination of hypoxia and IL-1beta caused a significant increase in MMP-1, MMP-3, MMP-9 and MMP-13 mRNA. | Hypoxia and IL-1beta increases MMPs |
Ogura et. Al. (2005) [40] | TNF-alpha | Human synovial membranes | Production of interleukin (IL)-8, growth-related oncogene (GRO)-alpha, monocyte chemoattractant protein (MCP)-1, and regulated upon activation normal T-cell expressed and secreted (RANTES) protein by synovial fibroblasts was increased by TNF-alpha. | Increased protein production of chemokines by synovial fibroblasts in response to TNF-alpha treatment. |
Sato et. Al. (2007) [41] | IL-8 | Human synovial tissues | IL-8 was up-regulated in inflamed synovial tissues in patients with internal derangement. | IL-8 associated with TMD with internal derangement |
Matsumoto et al. (2006) [42] | Cytokines | Human synovial fluid | In synovial fluid samples, angiogenin (Ang), fibroblast growth factor (FGF)-9, insulin-like growth factor-binding protein (IGFBP)-3, interleukin (IL)-1alpha, IL-1beta, IL-8, inducible protein (IP)-10, macrophage inflammatory protein (MIP)-1beta, osteoprotegerin (OPG), transforming growth factor (TGF)-beta2, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, tumor necrosis factor (TNF)-beta and vascular endothelial growth factor (VEGF) were detectable. Furthermore, the expression levels of Ang, brain-derived neurotrophic factor (BDNF), FGF-4, FGF-9, IGFBP-2, IL-8, MIP-1beta, OPG, pulmonary and activation-regulated protein (PARC), TGF-beta2, TIMP-2 and VEGF were significantly associated with the presence of JE; among these, nine cytokines (Ang, BDNF, FGF-4, FGF-9, IGFBP-2, MIP-1beta, PARC, TGF-beta2 and TIMP-2) were hitherto not described in TMD. | Cytokine expression and TMD |
Deschner et al. (2007) [43] | Insulin-like Growth Factor 1 | Rat discs | Continuous biophysical strain seems to downregulate the expression of the IGF system and may reduce the potential of fibrocartilage for growth and repair. | IGF-1 associated with TMJ strain |
Sato et al. (2007) [43] | IL-8 | Human synovial tissue | IL-8 was up-regulated in inflamed synovial tissues in patients with internal derangement. | IL-8 associated with TMD |
Ke et al. (2007) [44] | NF-kB and TNF-alpha | Human synovial fibroblasts | Activation of NF-kB is responsible for TNF-alpha-induced COX-2 expression in synovial fibroblasts from the TMJ. | NFkB, TNF-alpha, and COX-2 associated with TMD |
Tojyo et al. (2008) [45] | Hypoxia and interleukin-1beta | Human synovial fluid and discs | The combination of hypoxia and interleukin-1beta caused a significant increase in tenascin-C protein and mRNA of synovial fibroblasts, but not in disc cells. | Hypoxia and interleukin-1beta increase tenascin-C protein |
Leonardi (2011) [46] | TRAIL and DR5- and CASP3-dependent apoptosis | Human discs | Apoptosis involvement in the angiogenesis as a self-limiting process in patients with temporomandibular joint. | Apoptosis activation |
Kaneyama (2010) [23] | Cytokine Receptors | Human synovial fluid | Mean concentrations of cytokine receptors (tumor necrosis factor receptors I and II, interleukin (IL) 6 soluble receptor, IL-1 soluble receptor type II, and IL-1 receptor antagonist and protein)in the synovial fluid were significantly higher in the 30 joints with JE than in the 25 joints without JE. | Increase in cytokine receptor levels with TMD |
Leonardi et al. (2011) [47] | TNF-Related Apoptosis-Inducing Ligand Expression | Human discs | Cell loss due to the involvement of TRAIL apoptotic pathway seems, in part, responsible for TMJ disk degeneration. | Apoptosis and TMD |
Kim (2012) [48] | Granulocyte Macrophage Colony stimulating Factor (GM-CSF), interferon (INF), interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10 and tumor necrosis factor (TNF)-α | Human synovial fluid | Granulocyte Macrophage Colony stimulating Factor (GM-CSF), interferon (INF), interleukin (IL)-1β, IL-2, IL-6, IL-8, IL-10 and tumor necrosis factor (TNF)-α were detected in the TMD group, whereas no cytokines were detected in the control group. IL-4 and IL-5 were not detected in either the TMD group or in the control group. | Certain cytokines (noted left) associated with TMD |
Camejo (2013) [49] | Fas Ligand (FasL) | Human discs | A higher area of in situ immunostaining of FasL was found in temporomandibular discs with ADDwR 1. | Apoptosis and TMD |
Sicurezza (2013) [50] | β-Defensin | Human discs | The presence of β-defensin-4 in human TMJ discs affected by ADDwoR 2 was found, hypothesizing its possible role in articular bone disruption. | β-Defensin and disc degeneration |
Caporal et al. (2017) [29] | IL-6 | Human discs | No significant differences were observed between the groups ADDwR and ADDwoR, and with and without OA, in respect to the expression of IL-6. | No difference in IL-6 between two TMD groups |
Nakagawa et al. (2017) [49] | IFN-γ and TNF-α | Human synovial fluid | TNF-α and IFN-γ function in a cooperative manner to regulate inflammatory chemokine expression in synovial fibroblasts. | TNF-α and IFN-γ associated with inflammatory regulation in TMJ. |
Kaya et al. (2018) [50] | Chemerin | Human synovial fluid | Chemerin in synovial fluid may play a role as a predisposing factor and may represent a novel potential prognostic biochemical marker in the pathogenesis of TMJ disorders. | Chemerin associated with TMD |
Sorenson et al. (2018) [51] | IL-1 | Human synovial fluid | Articles that compared IL-1 concentrations in TMD vs. control groups found significant differences. | IL-1 associated with TMD |
Luo et al. (2019) [52] | IL-37b | Human synovial fluid | IL-37b suppressed inflammation and inhibited osteoclast formation. | Anti-inflammatory effects of IL-37. |
Authors | IHC Marker | Study Design and Tissue Expression | Results | Conclusions |
---|---|---|---|---|
Yoshida et al. (1996) [56] | Tenascin | Human synovial membranes | Synovial cells in the synovial membrane produce tenascin in the diseased human temporomandibular joint | Tenascin associated with TMD |
Yoshida et al. (1997) [28] | Tenascin | Human disc and synovial membranes | Tenascin is expressed specifically in the portion of the TMJ synovial membrane affected with internal derangement | Tenascin associated with degenerated tissue |
Mizoguchi et al. (1998) [5] | Biglycan, Decorin and Large Chondroitin-Sulphate Proteoglycan | Rat discs | Staining for biglycan was intense in the posterior band. In contrast, staining for decorin was faint in the intermediate zone and the central part of the posterior band, moderate in the anterior and posterior attachments and most intense in the junction between the anterior band and attachment. Similarly, there was intense staining for large chondroitin-sulphate proteoglycan in the peripheral band. | Presence of biglycan, decorin and large chondroitin-sulphate proteoglycan in disc. |
Kuwabara et al. (2002) [57] | Decorin and Biglycan | Rat discs | Regional differences in staining for decorin became prominent at 4, 8 and 16 weeks; decorin was more abundant in the peripheral area of the band than in the central area. In contrast, staining for biglycan was evenly distributed throughout the disc until 4 weeks, and after that became intense in the anterior and posterior bands. | Decorin and biglycan present in discs |
Leonardi et al. (2002) [58] | Vimentin and Alpha-Smooth Muscle Actin | Human discs | Vimentin is expressed by all disc cell populations and it does not appear to be influenced by any disease condition of the disc; on the other hand the up-regulation of alpha-SM actin immunolabelling seems to be correlated with histopathological findings of tears and clefts. | Localization of Vimentin and Alpha-Smooth Muscle Actin in TMJ discs |
Yoshida et al. (2002) [59] | Tenascin | Human synovial fluid and discs | Tenascin was produced specifically in synovial cells and vascular endothelial cells and. Fibroblasts were affected in the portion of TMJ with internal derangement. | Tenascin expression in TMD |
Kondoh et al. (2003) [60] | Type II Collagen | Human discs | The percentage of type II collagen in immunoreactive disc cells was significantly higher in the outer part (the articular surfaces) than in the inner part (the deep central areas) of the disc. | Increased collagen synthesis in TMJ discs |
Yoshida et al. (2004) [54] | Vimentin | Human discs and synovial membrane | There was an obvious distinction of vimentin immunoreactivity between the control specimens and internal derangement cases, in the posterior and/or anterior loose connective tissues. In particular, intensive vimentin expression was detected in the hypertrophic synovial membrane of internal derangement cases. | Vimentin present in synovial membrane of TMD |
Leonardi et al. (2004) [61] | Fibronectin | Human discs | The findings suggest that TMJ disc tissue can express fibronectin and that the expression is more pronounced in disc specimens of patients with internal derangements. | Fibronectin associated with internal derangements |
Paegle et al. (2005) [62] | Proteoglycans aggrecan, versican, biglycan, decorin, fibromodulin and hyaluronan synthase 1 | Human discs | Aggrecan expression was higher in patients with chronic closed lock. Within posterior disc attachment specimens, chronic closed lock showed a tendency for higher expression of biglycan and hyaluronan synthase 1. | Proteoglycans associated with chronic closed lock |
Toriya et al. (2006) [55] | Versican-core protein of a large chondroitin sulphate proteoglycan | Rat discs | Growth-related changes and regional differences exist in the expression of versican in the TMJ discs of growing rats. | Versican associated with TMD |
Moraes et al. (2008) [63] | Collagen Type IV | Human fetus discs | Marker of type IV collagen showed the presence of blood vessels in the central region of the temporomandibular disc. | Collagen present in disc formation |
Li et al. (2008) [64] | Hyaluronan and hyaluronan synthase | Human synovial membrane | IL-1beta functions on regulating HAS expression and consequently promoting the secretion of HA in synovial lining cells from TMJ. | Hyaluronan present in synovial membranes |
Natiella et al. (2009) [65] | Collagen Type I and Fibronectin | Human synovial fluid and discs | Disc specimens with advanced morphologic pathology showed significant labeling for fibronectin in 3 of 3 cases and for collagen I in 4 of 4 cases. There was no considerable difference in detection of either fibronectin or collagen I in TMJ synovial aspirates from patients with advanced disc pathology compared with controls. | Fibronectin found in pathologic TMJ discs |
Matsumoto et al. (2010) [66] | Hyaluronan and hyaluronan synthase (HAS) | Human discs | Hyaluronan synthase-3 is related to the pathological changes of human TMJ discs affected by ID. | HAS associated with TMJ degradation |
Kiga et al. (2010) [67] | Lumican, CD34 and vascular endothelial growth factor | Human discs | Assembly and regulation of collagen fibers. Lumican new collagen network by fibroblast-like cells. Presence of VEGF and CD34 inside the deformed disc. | Lumican expression associated with increased CD34 and VEGF in TMJ |
Fang et al. (2010) [68] | Chondromodulin-1 (ChM-1) | Rabbit discs | ChM-1 may play a role in the regulation of TMJ remodeling by preventing blood vessel invasion of the cartilage. | Anti-angiogenic factor in TMJ discs |
Kiga (2011) [69] | Lumican and fibromodulin under interleukin-1 beta (IL-1 β)-stimulated conditions | Human discs | Lumican and fibromodulin display different behaviors and that lumican may promote regeneration of the TMJ after degeneration and deformation induced by IL-1 β. | IL-1 β induces a significant increase in lumican mRNA, but not in fibromodulin mRNA. |
Leonardi et al. (2011) [70] | Lubricin | Human discs | A longstanding TMJ disc injury, affects lubricin expression in the TMJ disc tissue and not its surfaces; moreover, lubricin immunostaining is not correlated to TMJ disc histopathological changes. | No correlation between TMD and lubricin expression |
Leonardi et al. (2012) [71] | Lubricin | Human discs | Lubricin may have a role in normal disc posterior attachment physiology through the prevention of cellular adhesion as well as providing lubrication during normal bilaminar zone function. | Lubricin associated with TMJ homeostasis |
Hill et al. (2014) [72] | Lubricin | Rat synovial fluid | Lack of lubricin in the TMJ causes osteoarthritis-like degeneration that affects the articular cartilage as well as the integrity of multiple joint tissues. | Protective effects of lubricin on TMJ |
Shinohara et al. (2014) [73] | Tenascin-C (TNC) | Mice synovial fluid and disc | TNC was expressed in the wounded TMJ disc and mandibular fossa, lack of TNC may reduce fibrous adhesion formation in the TMJ. | TNC associated with TMD and fibrous adhesion formation |
Leonardi (2016) [74] | Lubricin | Human synovial fluid | Lubricin levels were inversely correlated with age and to Wilkes score. Lubricin decreases in synovial fluid with advanced disease. | Protective effects of lubricin on TMJ |
Authors | IHC Marker | Study Design and Tissue Expression | Results | Conclusions |
---|---|---|---|---|
Naqvi et al. (2004) [76] | Relaxin and β-estradiol | Rabbit discs | Relaxin and β-estradiol plus relaxin induced the MMPs collagenase-1 and stromelysin-1 in fibrocartilaginous explants, accompanied by a loss of GAGs and collagen but not altering the synthesis of GAGs. | Relaxin associated with degenerative effects on TMJ |
Hashem et al. (2006) [77] | Relaxin, β-estradiol, and progesterone alone or in various combinations. | Rabbit discs | Collagen caused by β-estradiol, relaxin, or β-estradiol + relaxin causes loss of disc glycosaminoglycans, Progesterone prevented relaxin- or β-estradiol-mediated loss of these molecules. | Estradiol and relaxin causes loss of glycosaminoglycans, and progesterone prevents it. |
Wang et al. (2008) [78] | Estrogen receptors α, β, relaxin receptors LGR7 and LGR8, and progesterone receptor | Mice discs | TMJ cells had higher ER-α (>2.8-fold), ER-β (>2.2-fold), LGR7 (>3-fold) and PR (>1.8-fold), and lower LGR8 (0.5-fold). | Estrogen, relaxin, and progesterone within TMJ discs |
Kapila et al. (2009) [11] | β-estradiol or relaxin and progesterone/estrogen receptors (ER)-α and –β, relaxin-1 receptor (RXFP1, LGR7), and INSL3 receptor (RXFP2, LGR8) | Rabbit discs | Relaxin produces a dose-dependent induction of tissue-degrading enzymes of the matrix metalloproteinase family, specifically MMP-1, MMP-3, MMP-9, and MMP-13 in cell isolates and tissue explants from TMJ fibrocartilage. The induction of these MMPs is accompanied by loss of collagen and glycosaminoglycans, which was blocked by a pan-MMP inhibitor. Progesterone attenuated the induction of MMPs. | Estrogen, relaxin, and progesterone within TMJ discs |
Puri et al. (2009) [75] | Estrogen receptor α | Rat disc and synovial fluid | The number of ER α -positive cells in the TMJ was not affected by inflammation or 17 beta-estradiol with exception of the retrodiscal tissue | Low estrogen receptor in normal TMJ |
McDaniel et al. (2014) [79] | Estrogen and progesterone | Baboon discs | Treatment of baboon TMJ disc cells with estrogen led to reduced PRG4 promoter activity and mRNA expression in vitro. | Negative regulation of PRG4 by estrogen. |
Park et al. (2019) [80] | Estrogen and progesterone | Mouse discs | Administration of Estrogen but not Progesterone caused a significant loss of TMJ collagen and glycosaminoglycans, accompanied by amplification of ERα and specific increases in MMP9 and MMP13 expression. | E2-mediated upregulation of MMP9 and MMP13. |
Authors | IHC Marker | Study Design and Tissue Expression | Results | Conclusions |
---|---|---|---|---|
Leonardi et al. (2002) [87] | Heat shock protein 27 | Human discs | HSP-27 upregulates in internal derangement specimens with major histopathological changes; it is not expressed or only weakly expressed in TMJ discs of fetuses and normal TMJ discs. | HSP-27 upregulation in TMD |
Huang et al. (2004) [82] | Bcl-2 and Bax | Rabbit discs | Chondrocyte cytoplasm in the disc exhibited a high intensity for Bcl-2, while Bax activity was only sporadically observed. Bcl-2 and Bax proteins are present in TMJ cartilage and their expression patterns suggest that these oncoproteins are involved in chondrocyte survival or death via apoptotic pathways. | Apoptotic pathways within TMJ discs |
Fujimura et al. (2006) [84] | Synovial fluid proteins | Human synovial fluid | Approximately 22 different protein bands with molecular weights ranging from 14 to 700 kd were clearly discernible on electrophoresis. The relative amounts of specific proteins in the SF of the TMD group were also different from those in the AS group (p < 0.05). The major difference in total protein concentration appeared to be due to the increased abundance of relatively high molecular weight proteins (>140 kd) in the TMD patients as compared to the AS group. | Increased concentration of synovial proteins associated with increased stage of TMD. |
Loreto (2012) [85] | Aquaporin | Human discs | AQP1 is normally expressed in the TMJ disc and confirm a role for it in the maintenance of TMJ homeostasis. | Aquaporin acts on TMJ homeostasis |
Loreto (2012) [85] | Aquaporin | Human discs | Aquaporin-1 is expressed and upregulated in temporomandibular joint with anterior disc displacement (both with and without reduction). | Channel protein involved in plasma membrane water permeability |
Jiang (2015) [81] | Dickkopf-related Protein 1 (DKK-1) | Human synovial fibroblasts | DKK-1 is associated with angiogenesis in the synovial fluid of patients with TMD. | DKK-1 associated with TMD |
Kobayashi (2017) [53] | Elastin-derived peptides | Human synovial fluid | Upregulation of IL-6 and MMP-12 expression by EDPs may be mediated through elastin-binding proteins (EBP) and a protein kinase A signaling cascade. | Elastin-derived peptides modulate the inflammatory cascade |
Castorina et al. (2019) [83] | P53 and VEGF | Human discs | P53 and VEGF expression in TMJ discs with internal derangement correlate with degeneration. | P53 and VEGF associated with TMD |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Almeida, L.E.; Doetzer, A.; Beck, M.L. Immunohistochemical Markers of Temporomandibular Disorders: A Review of the Literature. J. Clin. Med. 2023, 12, 789. https://doi.org/10.3390/jcm12030789
Almeida LE, Doetzer A, Beck ML. Immunohistochemical Markers of Temporomandibular Disorders: A Review of the Literature. Journal of Clinical Medicine. 2023; 12(3):789. https://doi.org/10.3390/jcm12030789
Chicago/Turabian StyleAlmeida, Luis Eduardo, Andrea Doetzer, and Matthew L. Beck. 2023. "Immunohistochemical Markers of Temporomandibular Disorders: A Review of the Literature" Journal of Clinical Medicine 12, no. 3: 789. https://doi.org/10.3390/jcm12030789
APA StyleAlmeida, L. E., Doetzer, A., & Beck, M. L. (2023). Immunohistochemical Markers of Temporomandibular Disorders: A Review of the Literature. Journal of Clinical Medicine, 12(3), 789. https://doi.org/10.3390/jcm12030789